Yashpal Singh Rawat: Fortis Memorial Research Institute Made Its Positive Mark at ASH
Yashpal Singh Rawat, Vice President and Facility Director at Fortis Healthcare, shared on LinkedIn:
”Fortis Memorial Research Institute made its positive mark at ASH in USA !
It is a moment of immense pride for all of us at Fortis Memorial Research Institute, Gurugram to witness our institution represented on the global stage at the American Society of Hematology (ASH) 2025 Annual Meeting in Orlando, USA- the most prestigious and influential conference in the field of hematology.
Dr. Rahul Bhargava’s podium oral presentation on “Dissecting India’s Molecular Hematology Landscape: A 1000-patient genomic study” marks not just a scientific achievement but a defining milestone for FMRI.
Taking FMRI’s research from Gurugram to an international platform of this calibre reflects the depth, rigor, and innovation of the work being done here.
This recognition is a testament to the dedication of the entire molecular hematology team-the scientists, clinicians, technologists, and collaborators whose relentless efforts made this study possible.
Your commitment to advancing genomic medicine in India has now been acknowledged at the highest level in global hematology.
Congratulations to Dr. Rahul Bhargava for representing FMRI with excellence, and kudos to every team member who contributed to this landmark achievement.
This is just the beginning, and we look forward to many more such accomplishments that continue to position FMRI as a leader in cutting-edge hematology research.
Proud moment for FMRI.
Proud moment for Fortis Family.”
All from ASH25 featured in Hemostasis Today.
-
May 7, 2026, 15:23Ahmed Nasreldein: Pleasure to Reconnect with Friends and Colleagues from Around the World at ESOC 2026
-
May 7, 2026, 15:14Meta-analysis of RCTs – International Journal of Stroke
-
May 7, 2026, 15:12Rob Maloney: Camp and the Power of Possibility for Children with Bleeding Disorders
-
May 7, 2026, 15:08Joseph R. Shaw: Individualized Risk-Adapted Perioperative Anticoagulation Management for APS Is Feasible and Safe
-
May 7, 2026, 15:00William Aird։ Not Every Clot Is DOAC Failure
-
May 7, 2026, 15:00What Hematologists Should Know About Pregnancy-Onset TTP – ASH Education
-
May 7, 2026, 14:54Matthias König: Developing an Open Whole-Body PBPK/PD Digital Twin of Apixaban
-
May 7, 2026, 14:48Honoring Compassion, Leadership, and Excellence in Hemophilia Care on National Nurses Day – Hemophilia Alliance
-
May 7, 2026, 14:18Rania Elsokkry: What is Atrial Fibrillation